Carl B. Camras | |
---|---|
Born | November 23, 1953 Glencoe, Illinois |
Died | April 14, 2009 |
Education | Yale University, Columbia University, UCLA |
Known for | Development of the prostaglandin analogues for the treatment of glaucoma |
Medical career | |
Profession | Ophthalmologist, Chairman UNMC Department of Ophthalmology and Visual Sciences |
Institutions | University of Nebraska Medical Center |
Research | Glaucoma |
Carl B. Camras (November 23, 1953 – April 14, 2009) was an American ophthalmologist known for his research on the treatment of glaucoma. He discovered a new class of drugs to treat glaucoma—prostaglandin analogues. Specifically, he developed latanoprost sold under the trade name Xalatan, which is the most widely used glaucoma medication.[1]